vs
Side-by-side financial comparison of VAALCO ENERGY INC (EGY) and RHYTHM PHARMACEUTICALS, INC. (RYTM). Click either name above to swap in a different company.
VAALCO ENERGY INC is the larger business by last-quarter revenue ($91.0M vs $57.3M, roughly 1.6× RHYTHM PHARMACEUTICALS, INC.). VAALCO ENERGY INC runs the higher net margin — -64.4% vs -83.0%, a 18.6% gap on every dollar of revenue. On growth, RHYTHM PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (36.9% vs -25.2%). Over the past eight quarters, RHYTHM PHARMACEUTICALS, INC.'s revenue compounded faster (48.5% CAGR vs -4.7%).
VAALCO Energy is a company engaged in hydrocarbon exploration. It is organized in Delaware and headquartered in Houston, Texas with operations primarily in the Etame Marin block offshore Gabon.
Rhythm Pharmaceuticals is a biopharmaceutical firm focused on developing and commercializing targeted therapies for rare genetic disorders causing severe unmanageable obesity, including POMC deficiency, LEPR deficiency, and Bardet-Biedl syndrome. It serves patients in North America and Europe who lack effective standard treatments for their chronic life-altering conditions.
EGY vs RYTM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $91.0M | $57.3M |
| Net Profit | $-58.6M | $-47.5M |
| Gross Margin | — | 91.6% |
| Operating Margin | -71.3% | -82.2% |
| Net Margin | -64.4% | -83.0% |
| Revenue YoY | -25.2% | 36.9% |
| Net Profit YoY | -602.5% | -9.6% |
| EPS (diluted) | $-0.56 | $-0.73 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $91.0M | $57.3M | ||
| Q3 25 | $61.0M | $51.3M | ||
| Q2 25 | $96.9M | $48.5M | ||
| Q1 25 | $110.3M | $32.7M | ||
| Q4 24 | $121.7M | $41.8M | ||
| Q3 24 | $140.3M | $33.3M | ||
| Q2 24 | $116.8M | $29.1M | ||
| Q1 24 | $100.2M | $26.0M |
| Q4 25 | $-58.6M | $-47.5M | ||
| Q3 25 | $1.1M | $-52.9M | ||
| Q2 25 | $8.4M | $-46.6M | ||
| Q1 25 | $7.7M | $-49.5M | ||
| Q4 24 | $11.7M | $-43.3M | ||
| Q3 24 | $11.0M | $-43.6M | ||
| Q2 24 | $28.2M | $-32.3M | ||
| Q1 24 | $7.7M | $-141.4M |
| Q4 25 | — | 91.6% | ||
| Q3 25 | — | 89.3% | ||
| Q2 25 | — | 88.6% | ||
| Q1 25 | — | 88.8% | ||
| Q4 24 | — | 90.9% | ||
| Q3 24 | — | 88.5% | ||
| Q2 24 | — | 89.9% | ||
| Q1 24 | — | 89.2% |
| Q4 25 | -71.3% | -82.2% | ||
| Q3 25 | 1.5% | -102.6% | ||
| Q2 25 | 17.7% | -93.4% | ||
| Q1 25 | 23.7% | -143.7% | ||
| Q4 24 | 32.7% | -98.6% | ||
| Q3 24 | 31.4% | -132.0% | ||
| Q2 24 | 17.5% | -139.2% | ||
| Q1 24 | 32.1% | -538.7% |
| Q4 25 | -64.4% | -83.0% | ||
| Q3 25 | 1.8% | -103.1% | ||
| Q2 25 | 8.6% | -96.1% | ||
| Q1 25 | 7.0% | -151.4% | ||
| Q4 24 | 9.6% | -103.6% | ||
| Q3 24 | 7.8% | -131.2% | ||
| Q2 24 | 24.1% | -110.9% | ||
| Q1 24 | 7.7% | -544.4% |
| Q4 25 | $-0.56 | $-0.73 | ||
| Q3 25 | $0.01 | $-0.82 | ||
| Q2 25 | $0.08 | $-0.75 | ||
| Q1 25 | $0.07 | $-0.81 | ||
| Q4 24 | $0.12 | $-0.71 | ||
| Q3 24 | $0.10 | $-0.73 | ||
| Q2 24 | $0.27 | $-0.55 | ||
| Q1 24 | $0.07 | $-2.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $58.9M | $388.9M |
| Total DebtLower is stronger | $60.0M | — |
| Stockholders' EquityBook value | $443.5M | $139.1M |
| Total Assets | $913.4M | $480.2M |
| Debt / EquityLower = less leverage | 0.14× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $58.9M | $388.9M | ||
| Q3 25 | $24.0M | $416.1M | ||
| Q2 25 | $67.9M | $291.0M | ||
| Q1 25 | $40.9M | $314.5M | ||
| Q4 24 | $82.7M | $320.6M | ||
| Q3 24 | $89.1M | $298.4M | ||
| Q2 24 | $62.9M | $319.1M | ||
| Q1 24 | $113.3M | $201.2M |
| Q4 25 | $60.0M | — | ||
| Q3 25 | $60.0M | — | ||
| Q2 25 | $60.0M | — | ||
| Q1 25 | $0 | — | ||
| Q4 24 | $0 | — | ||
| Q3 24 | $0 | — | ||
| Q2 24 | $0 | — | ||
| Q1 24 | $0 | — |
| Q4 25 | $443.5M | $139.1M | ||
| Q3 25 | $505.9M | $148.8M | ||
| Q2 25 | $511.6M | $-11.9M | ||
| Q1 25 | $504.1M | $18.9M | ||
| Q4 24 | $501.6M | $21.7M | ||
| Q3 24 | $501.0M | $11.2M | ||
| Q2 24 | $493.6M | $39.3M | ||
| Q1 24 | $472.6M | $61.6M |
| Q4 25 | $913.4M | $480.2M | ||
| Q3 25 | $950.4M | $506.9M | ||
| Q2 25 | $964.9M | $372.7M | ||
| Q1 25 | $927.1M | $386.7M | ||
| Q4 24 | $955.0M | $392.3M | ||
| Q3 24 | $937.9M | $363.6M | ||
| Q2 24 | $917.4M | $381.8M | ||
| Q1 24 | $809.1M | $258.7M |
| Q4 25 | 0.14× | — | ||
| Q3 25 | 0.12× | — | ||
| Q2 25 | 0.12× | — | ||
| Q1 25 | 0.00× | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | 0.00× | — | ||
| Q2 24 | 0.00× | — | ||
| Q1 24 | 0.00× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $145.2M | $-25.4M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $145.2M | $-25.4M | ||
| Q3 25 | $16.4M | $-26.6M | ||
| Q2 25 | $18.3M | $-23.3M | ||
| Q1 25 | $32.7M | $-40.4M | ||
| Q4 24 | $44.5M | $-18.8M | ||
| Q3 24 | $47.8M | $-25.2M | ||
| Q2 24 | $-438.0K | $-29.1M | ||
| Q1 24 | $21.8M | $-40.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $29.7M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 26.9% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 2.7% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | 14.94× | — | ||
| Q2 25 | 2.19× | — | ||
| Q1 25 | 4.23× | — | ||
| Q4 24 | 3.82× | — | ||
| Q3 24 | 4.35× | — | ||
| Q2 24 | -0.02× | — | ||
| Q1 24 | 2.84× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EGY
| Crude Oil Sales And Purchase Agreements | $54.8M | 60% |
| Other | $31.9M | 35% |
| Crude Oil | $3.0M | 3% |
| Natural Gas Liquids Reserves | $1.4M | 2% |
RYTM
Segment breakdown not available.
